Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Marrone Bio Innovations, Inc.    MBII

MARRONE BIO INNOVATIONS, INC.

(MBII)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/13/2021 01/14/2021 01/15/2021 01/19/2021 01/20/2021 Date
1.28(c) 1.35(c) 1.53(c) 1.62(c) 1.63(c) Last
231 462 1 443 216 1 749 764 1 432 710 784 682 Volume
0.00% +5.47% +13.33% +5.88% +0.62% Change
More quotes
Financials (USD)
Sales 2020 39,6 M - -
Net income 2020 -23,2 M - -
Net Debt 2020 - - -
P/E ratio 2020 -11,6x
Yield 2020 -
Sales 2021 55,1 M - -
Net income 2021 -16,0 M - -
Net Debt 2021 - - -
P/E ratio 2021 -17,8x
Yield 2021 -
Capitalization 249 M 249 M -
Capi. / Sales 2020 6,28x
Capi. / Sales 2021 4,51x
Nbr of Employees 133
Free-Float 99,2%
More Financials
Company
Marrone Bio Innovations, Inc. offers bio-based pest management and plant health products. The Company's bio-based products include naturally occurring microorganisms, such as bacteria, fungi and plant extracts. It sells its products to crop protection market. Its four crop protection products include Regalia, Grandevo, Venerate and Majestene. Its products are used in both conventional and organic crop production,... 
More about the company
Notations Surperformance© of Marrone Bio Innovations, Inc.
Trading Rating : Investor Rating :
More Ratings
All news about MARRONE BIO INNOVATIONS, INC.
03:45aUSING BIOLOGICALS & BEST PRACTICES T : Diseases
PU
01/14MARRONE BIO INNOVATIONS : Grandevo Bioinsecticide Gets Approved for Use in New Z..
MT
01/14Global Adoption of Biologicals Accelerates as Marrone Bio's Grandevo® WDG Bio..
GL
01/05MARRONE BIO INNOVATIONS : Announces Effectiveness of Form S-3 Resale Registratio..
AQ
01/05MARRONE BIO INNOVATIONS INC : Entry into a Material Definitive Agreement, Other ..
AQ
01/05Marrone Bio Provides Update on Warrant Transactions; No New Securities Offere..
GL
2020PGG Wrightson Seeds to Distribute Marrone Bio Innovations' Pro Farm UBP Seed ..
GL
2020INSIDER TRENDS : Marrone Bio Innovations Insider Reports Option Conversion Exten..
MT
2020MARRONE BIO INNOVATIONS : Files Up to 29.9 Million Common Shares on Behalf of Se..
MT
2020MARRONE BIO INNOVATIONS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL COND..
AQ
2020MARRONE BIO INNOVATIONS INC : Results of Operations and Financial Condition, Reg..
AQ
2020Earnings Flash (MBII) MARRONE BIO INNOVATIONS Reports Q3 Revenue $8.8M, vs. S..
MT
2020MARRONE BIO INNOVATIONS : Reports Third-Quarter 2020 Financial Results
AQ
2020Marrone Bio Innovations, Inc. Reports Third-Quarter 2020 Financial Results
GL
2020MARRONE BIO INNOVATIONS INC : Change in Directors or Principal Officers, Submiss..
AQ
More news
News in other languages on MARRONE BIO INNOVATIONS, INC.

- No features available -

More news
Chart MARRONE BIO INNOVATIONS, INC.
Duration : Period :
Marrone Bio Innovations, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MARRONE BIO INNOVATIONS, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Average target price 1,99 $
Last Close Price 1,63 $
Spread / Highest target 53,4%
Spread / Average Target 22,2%
Spread / Lowest Target -20,2%
EPS Revisions
Managers and Directors
NameTitle
Kevin R. Helash Chief Executive Officer & Director
James B. Boyd President & Chief Financial Officer
Robert A. Woods Chairman
Amit Vasavada Chief Technology Officer, Senior VP-R&D
Pamela G. Marrone Director
Sector and Competitors
1st jan.Capitalization (M$)
MARRONE BIO INNOVATIONS, INC.30.40%249
SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A.18.35%15 292
THE SCOTTS MIRACLE-GRO COMPANY11.71%12 182
ICL GROUP LTD8.25%6 999
PHOSAGRO8.87%6 024
UPL LIMITED23.53%5 890